Literature DB >> 22547260

Reproductive endocrinology: Infertility treatment in PCOS--is metformin in from the cold?

Evanthia Diamanti-Kandarakis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22547260     DOI： 10.1038/nrendo.2012.69

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

Review 1.  Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review.

Authors:  Christina Boots; Mary D Stephenson
Journal:  Semin Reprod Med       Date:  2011-12-08       Impact factor: 1.303

2.  Obesity and extreme obesity, manifest by ages 20-24 years, continuing through 32-41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy.

Authors:  Charles J Glueck; Swapna Dharashivkar; Ping Wang; Binghua Zhu; Peter S Gartside; Trent Tracy; Luann Sieve
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2005-10-01       Impact factor: 2.435

Review 3.  Infertility and pregnancy in women with polycystic ovary syndrome.

Authors:  S Nader
Journal:  Minerva Endocrinol       Date:  2010-12       Impact factor: 2.184

4.  Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial.

Authors:  Laure Morin-Papunen; Anni S Rantala; Leila Unkila-Kallio; Aila Tiitinen; Maritta Hippeläinen; Antti Perheentupa; Helena Tinkanen; Risto Bloigu; Katri Puukka; Aimo Ruokonen; Juha S Tapanainen
Journal:  J Clin Endocrinol Metab       Date:  2012-03-14       Impact factor: 5.958

5.  Prediction models for insulin resistance in the polycystic ovary syndrome.

Authors:  G Gennarelli; J Holte; L Berglund; C Berne; M Massobrio; H Lithell
Journal:  Hum Reprod       Date:  2000-10       Impact factor: 6.918

6.  Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

Authors:  R Pasquali; A Gambineri; D Biscotti; V Vicennati; L Gagliardi; D Colitta; S Fiorini; G E Cognigni; M Filicori; A M Morselli-Labate
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

7.  Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS.

Authors:  Evanthia Diamanti-Kandarakis; Dimitrios Panidis
Journal:  Clin Endocrinol (Oxf)       Date:  2007-08-29       Impact factor: 3.478

Review 8.  Role of metformin for weight management in patients without type 2 diabetes.

Authors:  Alicia R Desilets; Sushmita Dhakal-Karki; Kaelen C Dunican
Journal:  Ann Pharmacother       Date:  2008-05-13       Impact factor: 3.154

9.  Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response.

Authors:  Stefano Palomba; Angela Falbo; Tiziana Russo; Francesco Orio; Achille Tolino; Fulvio Zullo
Journal:  Hum Reprod       Date:  2010-01-26       Impact factor: 6.918

10.  Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.

Authors:  Bart C J M Fauser; Basil C Tarlatzis; Robert W Rebar; Richard S Legro; Adam H Balen; Roger Lobo; Enrico Carmina; Jeffrey Chang; Bulent O Yildiz; Joop S E Laven; Jacky Boivin; Felice Petraglia; C N Wijeyeratne; Robert J Norman; Andrea Dunaif; Stephen Franks; Robert A Wild; Daniel Dumesic; Kurt Barnhart
Journal:  Fertil Steril       Date:  2011-12-06       Impact factor: 7.329
  10 in total
  2 in total

1.  Menstrual pattern and menstrual disorders among adolescents: an update of the Italian data.

Authors:  Franco Rigon; Vincenzo De Sanctis; Sergio Bernasconi; Luigi Bianchin; Gianni Bona; Mauro Bozzola; Fabio Buzi; Giorgio Radetti; Luciano Tatò; Giorgio Tonini; Carlo De Sanctis; Egle Perissinotto
Journal:  Ital J Pediatr       Date:  2012-08-14       Impact factor: 2.638

2.  Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 Cascade.

Authors:  Fenqing Shang; Jiao Zhang; Zhao Li; Jin Zhang; Yanjun Yin; Yaqiong Wang; Traci L Marin; Brendan Gongol; Han Xiao; You-Yi Zhang; Zhen Chen; John Y-J Shyy; Ting Lei
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.